Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.

Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA Surg. 2016 08 17; 151(8):e161137.

View in: PubMed

subject areas

Aged
Antineoplastic Combined Chemotherapy Protocols
Camptothecin
Capecitabine
Carcinoma, Pancreatic Ductal
Chemoradiotherapy
Feasibility Studies
Female
Fluorouracil
Humans
Leucovorin
Male
Margins of Excision
Middle Aged
Neoadjuvant Therapy
Neoplasm, Residual
Organoplatinum Compounds
Pancreatectomy
Pancreatic Neoplasms
Pilot Projects
Prospective Studies
Radiotherapy, Intensity-Modulated
Survival Rate

authors with profiles

Hedy Kindler
Mark Talamonti